Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Notable Labs

Notable Labs
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B2 LATEST DEAL TYPE
$40M LATEST DEAL AMOUNT
30 INVESTORS
Description

Provider of drug testing services intended to help oncologists identify actionable treatment options for people with blood cancers. The company services prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor as well as involved in discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance, enabling patients to identify personalized cancer treatments options to cure their diseases.

Formerly Known As
StemCycle
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • 665 3rd Street
  • Suite 535
  • San Francisco, CA 94107
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Notable Labs’s full profile, request a free trial.

Notable Labs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC (Series B2) 16-Jul-2019 $40M 000.00 00000 Completed Generating Revenue
7. Early Stage VC (Series A1) 06-Sep-2017 000.00 000.00 000.00 Completed Generating Revenue
6. Early Stage VC 15-Mar-2017 00.000 00.000 Completed Generating Revenue
5. Early Stage VC 16-May-2016 00.000 00.000 Completed Startup
4. Early Stage VC 01-Jun-2015 00000 Completed Startup
3. Accelerator/Incubator 24-Mar-2015 00000 00000 00.000 Completed Startup
2. Early Stage VC 01-Mar-2015 Completed Startup
1. Early Stage VC 01-Aug-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Notable Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B-2 0,000,000 00.000000 00.00 00.00 00 00.00 000
Series B-1 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-6 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-5 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-4 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 1,194,403 $0.001000 $2.62 $2.62 1x $2.62 4.53%
Series A-1 3,583,743 $0.001000 $2.92 $2.92 1x $2.92 13.58%
To view this company’s complete Cap Table, request access »

Notable Labs Investors (30)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
B Capital Group Venture Capital Minority 000 0000 000000 0
Industry Ventures Venture Capital Minority 000 0000 000000 0
The Capital Group Companies Asset Manager Minority 000 0000 000000 0
Amplify Partners Venture Capital Minority 000 0000 000000 0
BoxGroup Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 30 investors. Get the full list »

Notable Labs Executive Team (9)

Name Title Board
Seat
Contact
Info
Matthew De Silva Co-Founder, Chief Executive Officer & Board Member
Peter Quinzio Co-Founder, Chief Financial Officer & and Board Member
Michael Horowitz Chief Operating Officer & General Counsel
Diane Heiser Ph.D Chief Technology Officer & Scientific Co-Founder
Lloyd MacKenzie Chief Development Officer

2 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

Notable Labs Board Members (3)

Name Representing Role Since Contact
Info
Jim Kim Builders VC Board Member 000 0000
Matthew De Silva Notable Labs Co-Founder, Chief Executive Officer & Board Member 000 0000
Peter Quinzio Notable Labs Co-Founder, Chief Financial Officer & and Board Member 000 0000